Can Scientists Control CAR-T?

Can Scientists Control CAR-T?
ASBMT/Kite Pharma via AP

Last August, in a milestone decades in the making, Kymriah became the first cell therapy to be approved by the U.S. Food & Drug Administration. Marketed by the Swiss giant Novartis, Kymriah is made by genetically engineering an individual's own immune cells to attack a form of leukemia.

Read Full Article »
Show comments Hide Comments

Related Articles